000			01727 a2200529 4500
005			20250514005259.0
264		0	_c20010920
008			200109s 0 0 eng d
022			_a0269-9370
024	7		_a10.1097/00002030-200107270-00008 _2doi
040			_aNLM _beng _cNLM
100	1		_aLichtenstein, K A
245	0	0	_aClinical assessment of HIV-associated lipodystrophy in an ambulatory population. _h[electronic resource]
260			_bAIDS (London, England) _cJul 2001
300			_a1389-98 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study
650	0	4	_aAcquired Immunodeficiency Syndrome _xdrug therapy
650	0	4	_aAdult
650	0	4	_aAge Factors
650	0	4	_aAnti-HIV Agents _xadverse effects
650	0	4	_aBody Mass Index
650	0	4	_aCD4 Lymphocyte Count
650	0	4	_aCohort Studies
650	0	4	_aData Interpretation, Statistical
650	0	4	_aFemale
650	0	4	_aHIV Protease Inhibitors _xadverse effects
650	0	4	_aHumans
650	0	4	_aIndinavir _xadverse effects
650	0	4	_aLipodystrophy _xchemically induced
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPrevalence
650	0	4	_aReverse Transcriptase Inhibitors _xadverse effects
650	0	4	_aRisk Factors
650	0	4	_aStavudine _xadverse effects
650	0	4	_aViral Load
700	1		_aWard, D J
700	1		_aMoorman, A C
700	1		_aDelaney, K M
700	1		_aYoung, B
700	1		_aPalella, F J
700	1		_aRhodes, P H
700	1		_aWood, K C
700	1		_aHolmberg, S D
773	0		_tAIDS (London, England) _gvol. 15 _gno. 11 _gp. 1389-98
856	4	0	_uhttps://doi.org/10.1097/00002030-200107270-00008 _zAvailable from publisher's website
999			_c11430063 _d11430063